Key Metrics
1.2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.2
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Indexed in the following public directories
-
Scopus -
DOAJ -
SJR
Journal Specifications
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 3000 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | European Organisation for Research and Treatment of Cancer (EORTC); European Association for Cancer Research (EACR); European CanCer Organisation (ECCO); European Society of Mastology (EUSOMA) |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 9 |
| Article Processing Charges | USD 3000 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
Planning to publish in European Journal of Cancer, Supplement ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients?
- 1 Nov 21
- European Journal of Cancer Supplements
-
Full paper
Editorial board
- 1 Nov 21
- European Journal of Cancer Supplements
-
Full paper
Use of [177Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study
- 1 Nov 21
- European Journal of Cancer Supplements
-
Full paper
Matching-adjusted indirect treatment comparison of [177Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [177Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours
- 1 Nov 21
- European Journal of Cancer Supplements
-
Full paper
Insight updating of the molecular hallmarks in ovarian carcinoma
- 1 Aug 20
- European Journal of Cancer Supplements
-
Full paper
The hallmarks of ovarian cancer: proliferation and cell growth
- 1 Aug 20
- European Journal of Cancer Supplements
Scite analysis
Powered by scite_
15.2k articles received 14.6k citations see all
- 568 Supporting
- 13,433 Mentioning
- 73 Contrasting
Editorial notices
- 1 Retractions
- 0 Withdrawals
- 0 Corrections
- 0 Errata
- 0 Expression of Concern
FAQs
How many articles did European Journal of Cancer, Supplement publish last years ?
In 2023, European Journal of Cancer, Supplement published articles.
What is the eISSN & pISSN for European Journal of Cancer, Supplement ?
For European Journal of Cancer, Supplement,eISSN is 1878-1217 and pISSN is1359-6349.
What is Citescore for European Journal of Cancer, Supplement ?
Citescore for European Journal of Cancer, Supplement is 1.2.
What is SNIP score for European Journal of Cancer, Supplement ?
SNIP score for European Journal of Cancer, Supplement is 0.2.
Who is the publisher of European Journal of Cancer, Supplement ?
Elsevier is the publisher of European Journal of Cancer, Supplement.